These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 2532471)

  • 21. The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women.
    Frölich M; Lachinsky N; Moolenaar AJ
    Acta Endocrinol (Copenh); 1977 Feb; 84(2):333-42. PubMed ID: 138326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hirsutism: diagnostic approach and stimulation-suppression dynamics of androgens in the female.
    Biberoglu K; Behrman SJ
    Int J Fertil; 1982; 27(3):146-52. PubMed ID: 6128319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time-dependent changes in serum 3 alpha-androstanediol glucuronide correlate with hirsutism scores after ovarian suppression.
    Carmina E; Stanczyk FZ; Gentzchein E; Lobo RA
    Gynecol Endocrinol; 1995 Sep; 9(3):215-20. PubMed ID: 8540291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disturbances of androgen secretion and metabolism in polycystic ovary syndrome.
    Lobo RA
    Clin Obstet Gynaecol; 1985 Sep; 12(3):633-47. PubMed ID: 2933204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum androstanediol glucuronide in women with facial hirsutism.
    Salman K; Spielvogel RL; Shulman LH; Miller JL; Vanderlinde RE; Rose LI
    J Am Acad Dermatol; 1992 Mar; 26(3 Pt 2):411-4. PubMed ID: 1564146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of obesity on hormonal parameters in hirsute and nonhirsute women.
    Bernasconi D; Del Monte P; Meozzi M; Randazzo M; Marugo A; Badaracco B; Marugo M
    Metabolism; 1996 Jan; 45(1):72-5. PubMed ID: 8544780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism of dihydrotestosterone to 5 alpha-androstane-3 alpha, 17 beta-diol glucuronide is greater in the peripheral compartment than in the splanchnic compartment.
    Duffy DM; Legro RS; Chang L; Stanczyk FZ; Lobo RA
    Fertil Steril; 1995 Oct; 64(4):736-9. PubMed ID: 7672144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum levels of 5-androstene-3 beta,17 beta-diol sulphate, 5 alpha-androstane-3 alpha, 17beta-diol sulphate and glucuronide, in late onset 21-hydroxylase deficiency.
    Montalto J; Funder JW; Yong AB; Whorwood CB; Connelly JF
    J Steroid Biochem Mol Biol; 1990 Nov; 37(4):593-8. PubMed ID: 2177625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma levels of C19 steroid glucuronides in pre-menopausal women with non-classical congenital adrenal hyperplasia.
    Whorwood CB; Ueshiba H; del Blazo P
    J Steroid Biochem Mol Biol; 1992 Apr; 42(2):211-21. PubMed ID: 1314640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
    Carmina E; Lobo RA
    Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
    Meczekalski B; Slopien R; Warenik-Szymankiewicz A
    Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Normal and elevated 3 alpha-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels.
    Pang S; Wang M; Jeffries S; Riddick L; Clark A; Estrada E
    J Clin Endocrinol Metab; 1992 Jul; 75(1):243-8. PubMed ID: 1535633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increase in plasma steroid glucuronide levels in men from infancy to adulthood.
    Brochu M; Belanger A
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1283-7. PubMed ID: 2952667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of androgens in menstrual disorders of nonhirsute and hirsute women, and the effect of glucocorticoid therapy on androgen levels in hirsute hyperandrogenic women.
    Ho Yuen B; Mincey EK
    Am J Obstet Gynecol; 1983 Jan; 145(2):152-7. PubMed ID: 6401396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of short- and long-term dexamethasone on 3 alpha-androstanediol glucuronide in hirsute women.
    Meikle AW; Odell WD
    Fertil Steril; 1986 Aug; 46(2):227-31. PubMed ID: 3015694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging.
    Labrie F; Bélanger A; Cusan L; Gomez JL; Candas B
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2396-402. PubMed ID: 9253307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androstanediol glucuronide plasma clearance and production rates in normal and hirsute women.
    Greep N; Hoopes M; Horton R
    J Clin Endocrinol Metab; 1986 Jan; 62(1):22-7. PubMed ID: 3940268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurements of 3 alpha,17 beta-androstanediol glucuronide in serum and urine and the correlation with skin 5 alpha-reductase activity.
    Paulson RJ; Serafini PC; Catalino JA; Lobo RA
    Fertil Steril; 1986 Aug; 46(2):222-6. PubMed ID: 3732528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Significance of sex hormone binding globulin and free androgen index in the estimation of androgenic cases].
    Qiao FY; Lauritzen C
    J Tongji Med Univ; 1990; 10(2):124-8. PubMed ID: 2145442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum 5-androstene-3 beta,17 beta-diol sulphate and 5 alpha-androstane-3 alpha,17 beta-diol sulphate in hirsute females with polycystic ovarian disease.
    Montalto J; Funder JW; Yong AB; Davies HE; Connelly JF
    J Steroid Biochem; 1990 Jun; 36(1-2):67-74. PubMed ID: 2362450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.